This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
Exec Summary: Remote photoplethysmography (rPPG) is a way of measuring vital signs, like your heart rate, but without touching you! It uses a camera to capture tiny changes in skin colour caused by blood flow. Here's a closer look at how it works: Light and Blood Flow: rPPG uses a regular camera and ambient light. As your heart pumps, blood volume in your skin changes slightly.
Virtual reality (VR) is one of the most cutting-edge digital technologies currently used to extend and adapt mental health interventions. When designing therapeutic VR-applications, bias related to representat.
Exec Summary: Orforglipron was originally discovered and developed by Chugai Pharmaceutical Co., Ltd. Eli Lilly licensed the worldwide development and commercialisation rights for Orforglipron from Chugai in 2018. Eli Lilly is currently running the clinical trials (phase 3) to see if Orforglipron is effective and safe for weight management and type 2 diabetes treatment.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Executive Summary: The future of telemedicine is expected to be bright, with a significant impact on healthcare delivery. Here are some key trends to watch: Increased Integration: Telemedicine is likely to become seamlessly integrated into standard healthcare practices. We can expect a hybrid model where virtual consultations complement in-person visits.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
97 
Let's personalize your content